2023
Press Releases
2022
Press Releases
-
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
-
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
-
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
-
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
2021
Press Releases
-
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
2020
Press Releases
-
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
-
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
-
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
-
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
